Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 83.38B | 82.85B | 86.42B | 77.52B | 114.24B |
Gross Profit | 24.15B | 21.98B | 19.83B | 17.03B | 18.07B |
EBITDA | 4.65B | 3.98B | 2.40B | 1.75B | 2.90B |
Net Income | 2.63B | 2.08B | 1.01B | 366.57M | 1.53B |
Balance Sheet | |||||
Total Assets | 79.20B | 74.07B | 73.03B | 64.70B | 68.10B |
Cash, Cash Equivalents and Short-Term Investments | 11.96B | 10.24B | 11.11B | 6.81B | 7.22B |
Total Debt | 13.34B | 12.34B | 14.03B | 9.40B | 11.13B |
Total Liabilities | 36.02B | 34.03B | 36.75B | 29.55B | 31.85B |
Stockholders Equity | 43.18B | 40.04B | 36.28B | 34.72B | 35.85B |
Cash Flow | |||||
Free Cash Flow | 3.88B | 1.29B | 726.87M | 2.73B | -1.56B |
Operating Cash Flow | 4.56B | 2.12B | 1.09B | 3.02B | -881.96M |
Investing Cash Flow | -3.37B | -1.39B | -1.06B | -1.37B | -876.84M |
Financing Cash Flow | 436.00M | -2.11B | 3.76B | -2.14B | 4.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥27.36B | 10.59 | 4.26% | 17.20% | 34.05% | ||
80 Outperform | ¥28.56B | 10.41 | 2.81% | 0.69% | 29.02% | ||
76 Outperform | ¥15.35B | 18.06 | 2.12% | -4.20% | 64.56% | ||
75 Outperform | ¥19.94B | 9.10 | 4.75% | 17.07% | -18.86% | ||
63 Neutral | €17.62B | 13.43 | 15.56% | 3.60% | -0.67% | -125.81% | |
59 Neutral | ¥15.91B | 22.65 | 2.65% | 1.27% | -43.97% | ||
55 Neutral | ¥19.15B | 20.09 | ― | 3.72% | -160.46% |